STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Resignation of Statutory Auditor
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science Limited has informed the exchange about a change in the statutory auditor of its UK-based wholly-owned material subsidiary, Strides Arcolab International Limited (SAIL). The previous auditor, MacIntyre Hudson LLP (MHA), ceased to act effective April 8, 2025, due to an internal restructuring where MHA separated its audit practice from non-audit services. Their audit engagements have been transitioned to a new dedicated audit entity, MHA Audit Services LLP, which has been appointed as the new statutory auditor of SAIL from the same date. The announcement was made on July 28, 2025, with a delay caused by clarifications sought by SAIL from MHA, which were received on July 25, 2025. There are no governance concerns, disputes, or other reasons behind the change — it is purely a firm-level structural change.
This is a routine administrative change limited to a UK subsidiary and does not affect Strides Pharma's Indian operations or its own statutory auditor. The new entity is essentially the same MHA audit team under a new LLP structure, so there is no material impact on shareholders or the stock price.